News

Article

10 I 26 phar­mind

The Gold Standard in Medical Device Advertising

How much scientific evidence is required for the advertising of a medical device?

Anyone who promotes therapeutic effects must be able to substantiate them with scientifically sound evidence. But can the “gold standard” developed for pharmaceuticals be applied without reservation to medical devices? For example, how are placebo-controlled, double-blind studies supposed to be conducted for implants when ethical and practical limitations stand in the way?

My colleague Dominik Kollmar from our Bad Homburg office and I address these questions in our latest article, “The Gold Standard in Medical Device Advertising,” in the trade journal “die pharmazeutische industrie.”

The focus is on three practical aspects:

🔹 Scientific validation requires a nuanced approach. The specific characteristics of the respective medical device and the specific claim being advertised must be taken into account. A blanket application of the requirements from the pharmaceutical sector falls short.

🔹 CE certification is not an official drug approval. However, it can serve as a significant indicator of the scientific validity of an advertising claim, if that claim was the subject of the relevant review in the conformity assessment procedure. Case law on this matter has not yet been consistent.

🔹 Particular care must be taken with “Data on File” and when citing studies. Unpublished internal studies must be clearly identifiable as such. Likewise, limitations on the validity of a study must not be overlooked in advertising.

For manufacturers, this means: scientific evidence, regulatory documentation, and promotional communications must be carefully coordinated. This creates legal certainty and strengthens confidence in medical innovations.

04 I 26 RPG

An Interview with Alexander Ehlers on the Future of Primary Care

How can we ensure reliable, cross-sector care for patients? This question is the focus of an interview by Alexander P. F. Ehlers with Nikolaus Huss in the current issue (4/2026) of the journal *Recht und Politik im Gesundheitswesen* (RPG).

Under the title “The German Health Care System: Restructuring, Competition, and Accountability,” the two will discuss the necessary structural and financial changes in the German healthcare system. The focus is in par­ticular on better co­ordi­na­tion between out­patient and in­patient care, funding oriented toward the entire course of treatment, and the question of the future role of the legislature, self-governance, and competition.

The interview appeared in RPG, Volume 32, Issue 4/2026, on pages 82–85.

Awards

🏆Best Law Firms® — Germany 2027:
— Biotechnology Law and Life Sciences
— Health Care Law Litigation
— Pharmaceuticals Law

🏆JUVE Handbook of Business Law Firms 2026/2027: Recommendation in the Core Area of Medical and Pharmaceutical Law

🏆F.A.Z. Institute Special Publication: “TOP Lawyer 2027” in Medical Law: Anja Oehmi-chen, Dr. Alexander Oehmi-chen, Dominik Kollmar

🏆Handelsblatt: Germany's Best Law Firms 2026

🏆Handelsblatt: Germany's Best Lawyers 2025

Events

Ehlers Legal Supports the 2026 Charity Award

At the 2026 Springer Medicine Gala in Berlin, outstanding achievements in medical research and exceptional social commitment to public healthsector.

Ehlers Legal has been a sponsor of the Charity Award since its inception. The award honors initiatives that demonstrate exceptional dedication to helping people in the healthcare sector. This year’s award recipients include, among others, projects aimed at supporting children in the hospital, strengthening volunteer work, and raising the profile of nursing.
 
As a law firm specializing in medical, health, and pharmaceutical law, social engagement is an important part of Ehlers Legal’s own responsibility within the healthcare sector.
 
Ehlers Legal congratulates all the award-winning initiatives and looks forward to continuing to support the Charity Award in the future.

Press release

Our newsletter

January 15, 2025

German version

English version

Sign up for our newsletter

Your registration could not be saved. Please try again.
Your registration was successful.
title

Newsletter

Subscribe to our newsletter to stay up to date.

We use Brevo as our marketing platform. By submitting the form, you agree that the personal information you provide will be transferred to Brevo for processing in accordance with Brevo's privacy policy.

Scroll up